Short Interest in Curative Biotechnology, Inc. (OTCMKTS:CUBT) Decreases By 24.5%

Curative Biotechnology, Inc. (OTCMKTS:CUBTGet Free Report) was the recipient of a significant drop in short interest in May. As of May 31st, there was short interest totalling 24,300 shares, a drop of 24.5% from the May 15th total of 32,200 shares. Based on an average trading volume of 487,900 shares, the days-to-cover ratio is presently 0.0 days.

Curative Biotechnology Price Performance

Shares of OTCMKTS CUBT remained flat at $0.02 during mid-day trading on Friday. 27,871 shares of the company traded hands, compared to its average volume of 177,438. Curative Biotechnology has a 12 month low of $0.01 and a 12 month high of $0.04. The business’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.02.

Curative Biotechnology Company Profile

(Get Free Report)

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.

Featured Articles

Receive News & Ratings for Curative Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curative Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.